LNTH
- Lantheus Holdings, Inc.
()
Overview
Company Summary
Lantheus Holdings, Inc. is a company that operates in the healthcare sector, specifically in the field of diagnostic medical imaging. The company is focused on developing, manufacturing, and commercializing innovative diagnostic imaging agents and products that assist medical professionals in diagnosing and treating various diseases and conditions.
Lantheus specializes in contrast agents, which are substances that enhance the visibility of internal body structures during medical imaging procedures such as MRI (Magnetic Resonance Imaging), CT (Computed Tomography), and ultrasound. These agents help improve the accuracy and reliability of medical diagnoses by providing clearer and more detailed images.
The company offers a diverse portfolio of imaging agents, including both injectable and oral options, designed for different diagnostic procedures. These agents are used to visualize the cardiovascular system, liver, kidneys, and other organs, facilitating the identification of abnormalities, tumors, or other conditions.
In addition to imaging agents, Lantheus also provides related medical devices and services to support the use of their products in healthcare facilities. Their offerings include contrast delivery systems, syringe management technologies, and patient monitoring tools.
Lantheus Holdings, Inc. primarily serves medical professionals in hospitals, clinics, and imaging centers worldwide. The company's mission is to improve patient care by delivering safe and effective diagnostic imaging solutions that enable accurate diagnoses and optimal treatment decisions.